Bryony Henderson Medical Director, UK MBBS, BSc, DFFP, MRCGP Dr
Unfortunately, we are also seeing a rise in numbers among younger adults under the age of 50
placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
It typically develops with age and most frequently occurs in the hands, hips and knees
Back Wu, AY, Stokes, R, Peebles, R (6 Sept 2021) 'The GLP-1 receptor in airway inflammation in asthma: a promising novel target?' Expert Review of Clinical Immunology , 17/10, 105357
This includes his ban on the use of thimerosal, a preservative containing a very small amount of ethylmercury, in multidose flu vaccine vials
